Pharmaceuticals, Biotechnology and Life Sciences
REHOVOT, Israel & WILMINGTON, Del.–(BUSINESS WIRE)–Ayala Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company dedicated to developing targeted cancer therapies for people…
PRINCETON, N.J.–(BUSINESS WIRE)–Advaxis, Inc. (Nasdaq: ADXS), a clinical-stage biotechnology company focused on the discovery, development and commercialization of immunotherapy products,…
New EndoScan-V™ endotoxin detection software and Celsis® automated detection platform for rapid sterility introduced to address unmet industry needs WILMINGTON,…
— Protective mechanism of action for investigational drug, now in Phase 2 studies in early Alzheimer’s disease and Fragile X…
SAN FRANCISCO–(BUSINESS WIRE)–BlackThorn Therapeutics, Inc., a clinical-stage, neurobehavioral health company pioneering next-generation artificial intelligence (AI) technologies to advance targeted therapeutics,…
— If Approved, Teprotumumab Would be the First FDA-Approved Medicine for this Vision-Threatening Disease — DUBLIN–(BUSINESS WIRE)–Horizon Therapeutics plc (Nasdaq:…
DUBLIN–(BUSINESS WIRE)–US The “Influenza Vaccines in the United States – Market Size, Trends, Opportunities and Growth Potential” report has been…
– Phase 2 Clinical Trial of KVD900 for On-Demand Oral Treatment of Hereditary Angioedema (HAE) Attacks Expected to Complete in…
Data to be presented include analyses of long-term efficacy and safety of ozanimod in adults with relapsing forms of multiple…
– Eidos grants Alexion exclusive license to develop and commercialize AG10 in Japan – – Phase 3 study of AG10…